tiprankstipranks
Trending News
More News >
Lipigon Pharmaceuticals AB (DE:9RP)
FRANKFURT:9RP
Germany Market

Lipigon Pharmaceuticals AB (9RP) Financial Statements

Compare
0 Followers

Lipigon Pharmaceuticals AB Financial Overview

Lipigon Pharmaceuticals AB's market cap is currently €1.25M. The company's EPS TTM is €-0.015; its P/E ratio is ―; Lipigon Pharmaceuticals AB is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuekr 16.41Mkr 390.00Kkr 3.18Mkr 4.28Mkr 1.74M
Gross Profitkr -5.12Mkr 366.00Kkr -39.95Mkr -7.70Mkr -3.66M
Operating Incomekr -12.37Mkr -37.74Mkr -41.19Mkr -7.82Mkr -4.93M
EBITDAkr -12.10Mkr -37.68Mkr -41.09Mkr 0.00kr 0.00
Net Incomekr -12.13Mkr -37.67Mkr -41.12Mkr -8.31Mkr -5.04M
Balance Sheet
Cash & Short-Term Investmentskr 31.93Mkr 9.64Mkr 28.47Mkr 12.55Mkr 2.49M
Total Assetskr 33.60Mkr 10.82Mkr 29.43Mkr 15.24Mkr 3.21M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -31.93Mkr -9.64Mkr -28.47Mkr -12.55Mkr -1.04M
Total Liabilitieskr 5.16Mkr 6.95Mkr 6.47Mkr 2.26Mkr 1.04M
Stockholders' Equitykr 28.45Mkr 3.87Mkr 22.96Mkr 12.98Mkr 2.17M
Cash Flow
Free Cash Flowkr -14.32Mkr -37.47Mkr -35.42Mkr -8.63Mkr -5.56M
Operating Cash Flowkr -14.32Mkr -37.47Mkr -35.30Mkr -8.63Mkr -5.56M
Investing Cash Flowkr 0.00kr 0.00kr -119.00Kkr 1.25Mkr -1.50M
Financing Cash Flowkr 36.70Mkr 18.61Mkr 51.09Mkr 18.88Mkr 8.00M
Currency in SEK

Lipigon Pharmaceuticals AB Earnings and Revenue History

Lipigon Pharmaceuticals AB Debt to Assets

Lipigon Pharmaceuticals AB Cash Flow

Lipigon Pharmaceuticals AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis